drugset / Trial / NCT00319189
Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The objective of the present study is to evaluate both the efficacy and safet of nateglinide in renal transplanta recipients with posttransplant diabetes mellitus or impaired glucose tolerance. Primarily will the change in glucose tolerance and acute insuline responce be addressed.
Timeline
- Start
- 2002-11
- Primary completion
- —
- Completion
- 2003-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nateglinide | Small molecule | — | — |